A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy

Journal of Spinal Cord Medicine

Volumn 20, Issue 4, 1997, Pages 402-405

  Spivack, Stacy B ^a   Aisen, Mindy L ^a,b  

^a BURKE REHABILITATION HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Anticoagulation; Deep vein thrombosis; Heparin; Pulmonary embolism; Spinal cord injury

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SPINAL CORD DISEASE; THROMBOPHLEBITIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH CARE COSTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SPINAL CORD DISEASES; THROMBOPHLEBITIS;

EID: 0031254357     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.1997.11719497     Document Type: Review

References (10)

1. Stallman JS, Aisen PS, Aisen ML. Pulmonary embolism presenting as fever in spinal cord injury patients: report of two cases and review of literature. J Amer Paraplegia Soc 1993;16:157-9.
2. Borris LC, Lassen MR, Andersen BS, et al. Low molecular weight heparin (enoxaparin) versus standard heparin in the prevention of venous thromboembolism in operatively treated hip fracture patients. Thromb Haemost 1993;69:2058.
3. Macouillard G, Castagners L, Claverie AJ, et al. Prevention of pulmonary embolism in spinal cord injured patients: comparison of low fixed-dose heparin versus low molecular weight heparin. Thromb Haemost 1995;73:978.
4. Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995;108:312S-334S.
5. Maynard FM. International standard for neurological and functional classification of spinal cord injuries. New York; American SCI Association 1996.
6. Bergqvist D, Lindgren B, Matzsch T. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin. Br J Surg 1996;83:1548-52.
7. Harris S, Chen D, Green D. Enoxaparin for thromboembolism prophylaxis in spinal injury: preliminary report on experience with 105 patients. Am J Phys Med Rehabil 1996;75:326-7.
8. Volteas SK, Kalodiki E, Nicolaides AN. Low molecular weight heparins in the initial treatment of deep vein thrombosis. Int Angiol 1996;15:67-74.
9. Fishman A, Altaras M, Klein Z, Aviram R, Beyth Y. Low molecular weight heparin (Enoxaparin) as an alternative treatment of acute deep vein thrombosis in gynecologic oncology patients. Eur J Gynecol Oncol 1996;17:365-7.
10. Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost 1996;22:77-91.